Bank of America’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Bank of America's RXST Position: Q2 2026 in Review
Bank of America reduced its RxSight (RXST) stake by 60% in Q2 2026, selling an estimated $4.37M and leaving 485,298 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #4111.
Bank of America first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $86.3M in Q3 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- Bank of America held 485,298 shares of RxSight worth $2.34M as of Q2 2026.
- Bank of America sold 724,741 RxSight shares in Q2 2026, an estimated $4.37M.
- RxSight made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4111 holding.
- Bank of America first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
- Bank of America's RxSight position peaked at $86.3M in Q3 2024.
- 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.